These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4751886)

  • 1. [Administration of sorbitol infusion to patients with chronic renal failure and to patients with liver cirrhosis].
    Strec V; Zajacová O; Dzúriková V
    Bratisl Lek Listy; 1973; 59(4):436-44. PubMed ID: 4751886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of sorbitol].
    Bogomolova LG; Suslov VS
    Klin Med (Mosk); 1973 Jun; 51(6):108-14. PubMed ID: 4204350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic reflection of fructose, xylitol and sorbitol infusion in healthy persons and in persons with cirrhosis].
    Brodanová M; Brodan V; Kordac V; Marecek Z; Filip J; Slabochová Z
    Cesk Fysiol; 1973; 22(6):585-8. PubMed ID: 4779514
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polystyrene sodium sulfonate enema: with or without sorbitol?].
    Marion F; Joye F
    Presse Med; 1999 Feb; 28(7):338. PubMed ID: 10083877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic effects of parenteral administration of glucose, fructose, sorbitol and xylitol in cirrhotic and healthy subjects].
    Brodanová M; Brodan V; Filip J; Kuhn E
    Cas Lek Cesk; 1976 Apr; 115(13):387-93. PubMed ID: 1260815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stimulation of intestinal peristalsis by intraperitoneal and intravenous administration of sorbitol].
    Kutushev FKh; Volkova SD; Chirkova OO
    Vestn Khir Im I I Grek; 1972 Aug; 109(8):17-21. PubMed ID: 4566070
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
    Bissoli F; Gini G; Bosio M; Ceriani R
    Recenti Prog Med; 1996 May; 87(5):227-8. PubMed ID: 8767760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Branched-chain amino acids and their ketoanalogs: therapeutic uses in patients with chronic liver or kidney failure].
    Bode JC
    Internist (Berl); 1985 Jul; 26(7):388-98. PubMed ID: 3897107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of sorbitol in oncologic practice].
    Firsova PP; Dunchik VN; Filatova NM; Tolstykh PI; D'iakova AM
    Sov Med; 1973 Feb; 36(2):114-7. PubMed ID: 4764965
    [No Abstract]   [Full Text] [Related]  

  • 10. Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease.
    Pimstone BL; Le Roith D; Epstein S; Kronheim S
    J Clin Endocrinol Metab; 1975 Aug; 41(2):392-3. PubMed ID: 1159052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for the use of keto-analogs in internal medicine].
    Fiaccadori F; Elia GF; Lehndorff H; Pizzaferri P; Pedretti G
    Ann Ital Med Int; 1987; 2(2):143-9. PubMed ID: 3079446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of an orotic acid-sorbitol combination in hepato-intestinal diseases. Point of view of a general practitioner].
    Lechat S; Pattin S; Vigne J
    Rev Corps Sante Armees Terre Mer Air; 1967 Apr; 8(2):259-66. PubMed ID: 4237949
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum lipids in chronic kidney failure and their modification with glucose and sorbitol during peritoneal dialysis].
    Reimold WV; Kattermann R; Quellhorst E
    Arch Klin Med; 1969; 216(5):384-401. PubMed ID: 5371209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbohydrate infusions in internal diseases. A comparative study in metabolically normal subjects, patients with liver diseases and diabetics. V. Infusion of a glucose-sorbitol mixture (ratio 1:1) for 48 hours].
    Müller PH; Egberts EH; Beerenfeld A; Schmülling R; Prestele H; Horbach L; Malchow H
    Infusionsther Klin Ernahr; 1982 Feb; 9(1):16-9. PubMed ID: 7076289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of sorbitol in the treatment of postoperative intestinal paralysis (clinico-experimental study)].
    Korostovtseva NV; Kal' EA; Chirkova OO; Volkova SD
    Vestn Khir Im I I Grek; 1971 May; 106(5):36-40. PubMed ID: 5139680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance].
    Locher S
    Anasth Intensivther Notfallmed; 1987 Aug; 22(4):194-7. PubMed ID: 3116878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of lyophilized sorbitol for the prevention and treatment of postoperative intestinal paresis].
    Kutushev FKh; Volkova SD
    Vestn Khir Im I I Grek; 1971 May; 106(5):32-6. PubMed ID: 5139679
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of amiloride hydrochloride (MK-870) in patients with cirrhosis.
    Grayer D; Iber F
    Johns Hopkins Med J; 1969 Aug; 125(2):78-83. PubMed ID: 5347782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of Nutrimade in hypoalbuminemia].
    Pozuelo A
    Rev Clin Esp; 1971 Mar; 120(6):557-62. PubMed ID: 5164800
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional renal failure in cirrhosis.
    Lieberman FL
    Gastroenterology; 1970 Jan; 58(1):108-10. PubMed ID: 5410446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.